• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服吸附剂AST-120(可利美净)对肾大部切除大鼠早期肾衰竭肾功能及肾小球损伤的影响

Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats.

作者信息

Kobayashi Noriyoshi, Maeda Atsuko, Horikoshi Satoshi, Shirato Isao, Tomino Yasuhiko, Ise Michihito

机构信息

Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

出版信息

Nephron. 2002 Jul;91(3):480-5. doi: 10.1159/000064291.

DOI:10.1159/000064291
PMID:12119481
Abstract

The aim of the present study was to determine if treatment with an oral adsorbent (AST-120, Kremezin) might decrease the urinary albumin excretion and serum indoxyl sulfate (s-IS), and prevent glomerular sclerosis in early-stage renal failure, i.e. 0.9-1.2 mg/dl of serum creatinine (s-Cr) and 60-95 mg/dl of blood urea nitrogen (BUN), in subtotal (3/4) nephrectomized rats. Levels of s-Cr and s-IS in the AST-120-treated rats were significantly lower than those in the untreated control rats. The AST-120-treated rats showed an increase of creatinine clearance. Urinary protein and indoxyl sulfate excretion in the AST-120-treated rats were also significantly lower than those in the untreated control rats. The ratio of glomerular tuft area to the area of Bowman's capsules (GT/BC) in the AST-120-treated rats was significantly lower than that in the untreated control rats. The degree of glomerular sclerosis and tubulointerstitial fibrosis in the AST-120-treated rats was significantly lower than that in the untreated control rats. Furthermore, there was a significant relationship among the degree of GT/BC, glomerular sclerosis, tubulointerstitial fibrosis and the levels of urinary protein excretion. It appears that AST-120 might decrease the accumulation of s-Cr and s-IS, and prevent glomerular sclerosis in early stage renal failure in the subtotal nephrectomized rats.

摘要

本研究的目的是确定口服吸附剂(AST-120,可利美净)治疗是否可能降低尿白蛋白排泄和血清硫酸吲哚酚(s-IS),并预防大鼠肾大部(3/4)切除术后早期肾衰竭(即血清肌酐(s-Cr)为0.9 - 1.2mg/dl和血尿素氮(BUN)为60 - 95mg/dl)时的肾小球硬化。AST-120治疗组大鼠的s-Cr和s-IS水平显著低于未治疗的对照组大鼠。AST-120治疗组大鼠的肌酐清除率有所增加。AST-120治疗组大鼠的尿蛋白和硫酸吲哚酚排泄也显著低于未治疗的对照组大鼠。AST-120治疗组大鼠的肾小球毛细血管丛面积与鲍曼囊面积之比(GT/BC)显著低于未治疗的对照组大鼠。AST-120治疗组大鼠的肾小球硬化和肾小管间质纤维化程度显著低于未治疗的对照组大鼠。此外,GT/BC程度、肾小球硬化、肾小管间质纤维化与尿蛋白排泄水平之间存在显著相关性。似乎AST-120可能减少s-Cr和s-IS的蓄积,并预防肾大部切除术后早期肾衰竭大鼠的肾小球硬化。

相似文献

1
Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats.口服吸附剂AST-120(可利美净)对肾大部切除大鼠早期肾衰竭肾功能及肾小球损伤的影响
Nephron. 2002 Jul;91(3):480-5. doi: 10.1159/000064291.
2
An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats.一种口服吸附剂可改善糖尿病大鼠硫酸吲哚酚的肾脏负荷及肾衰竭进展。
Am J Kidney Dis. 2001 Jan;37(1 Suppl 2):S7-S12. doi: 10.1053/ajkd.2001.20731.
3
Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats.贝那普利与口服吸附剂联合治疗可改善尿毒症大鼠的进行性肾纤维化。
Nephron. 2002 Mar;90(3):297-312. doi: 10.1159/000049066.
4
An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys.一种口服吸附剂可减轻尿毒症大鼠肾脏中硫酸吲哚酚的负荷及转化生长因子β1的基因表达。
Nephrol Dial Transplant. 2000 Nov;15(11):1773-81. doi: 10.1093/ndt/15.11.1773.
5
Oral sorbent AST-120 increases renal NO synthesis in uremic rats.口服吸附剂AST-120可增加尿毒症大鼠的肾脏一氧化氮合成。
J Ren Nutr. 2008 Jan;18(1):60-4. doi: 10.1053/j.jrn.2007.10.013.
6
Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.硫酸吲哚酚是一种循环性尿毒症毒素,可促进肾小球硬化的进展。
J Lab Clin Med. 1994 Jul;124(1):96-104.
7
Effects of oral carbonic adsorbent (AST-120) on kidney of early-stage chronic kidney disease rats.口服碳酸吸附剂(AST-120)对早期慢性肾病大鼠肾脏的影响。
Ren Fail. 2015 Mar;37(2):337-42. doi: 10.3109/0886022X.2014.986006. Epub 2014 Nov 26.
8
[Study on the initiation time of drug treatment for chronic renal failure].[慢性肾衰竭药物治疗起始时间的研究]
Nihon Jinzo Gakkai Shi. 1993 Jun;35(6):765-76.
9
[The effects of oral adsorbent (AST-120) in the experimental model of chronic renal failure--pathophysiological study on renal function, glomerular hypertrophy, mesangial function and glomerular histology].
Nihon Jinzo Gakkai Shi. 1990 Sep;32(9):1001-8.
10
Oral adsorbent ameliorates renal TGF-beta 1 expression in hypercholesterolemic rats.口服吸附剂可改善高胆固醇血症大鼠肾脏中转化生长因子β1的表达。
Kidney Int Suppl. 1999 Jul;71:S193-7. doi: 10.1046/j.1523-1755.1999.07150.x.

引用本文的文献

1
Impact of using oral spherical carbon adsorbent in predialysis chronic kidney disease period on cardiovascular outcome after dialysis therapy.透析前慢性肾脏病期使用口服球形碳吸附剂对透析治疗后心血管结局的影响。
Sci Rep. 2025 Feb 21;15(1):6315. doi: 10.1038/s41598-025-90779-6.
2
The Ability of AST-120 to Lower the Serum Indoxyl Sulfate Level Improves Renal Outcomes and the Lipid Profile in Diabetic and Nondiabetic Animal Models of Chronic Kidney Disease: A Meta-Analysis.AST-120降低血清硫酸吲哚酚水平的能力改善慢性肾脏病糖尿病和非糖尿病动物模型的肾脏结局及脂质谱:一项荟萃分析
Toxins (Basel). 2024 Dec 16;16(12):544. doi: 10.3390/toxins16120544.
3
Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication.
肠内分泌细胞和肠道激素作为肠-肾轴通讯交叉点的潜在靶点。
Front Pharmacol. 2023 Oct 19;14:1248757. doi: 10.3389/fphar.2023.1248757. eCollection 2023.
4
Animal Models for Studying Protein-Bound Uremic Toxin Removal-A Systematic Review.研究蛋白结合型尿毒症毒素清除的动物模型:系统评价。
Int J Mol Sci. 2023 Aug 25;24(17):13197. doi: 10.3390/ijms241713197.
5
Effect of Renamezin upon attenuation of renal function decline in pre-dialysis chronic kidney disease patients: 24-week prospective observational cohort study.雷美替胺对透析前慢性肾脏病患者肾功能下降的衰减作用:24 周前瞻性观察性队列研究。
PLoS One. 2021 Jun 7;16(6):e0252186. doi: 10.1371/journal.pone.0252186. eCollection 2021.
6
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.对慢性肾脏病的影响以及 AST-120 的缓解作用。
Toxins (Basel). 2018 Sep 11;10(9):367. doi: 10.3390/toxins10090367.
7
Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand.硫酸吲哚酚(一种尿毒症毒素和芳烃受体配体)引起的足细胞损伤。
PLoS One. 2014 Sep 22;9(9):e108448. doi: 10.1371/journal.pone.0108448. eCollection 2014.
8
Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats.AST-120对腺嘌呤诱导的尿毒症大鼠内皮功能障碍的影响。
Int J Nephrol. 2014;2014:164125. doi: 10.1155/2014/164125. Epub 2014 Apr 14.
9
The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction.尿毒症毒素吸附剂AST-120可减轻心肌梗死后的心肾损伤。
PLoS One. 2013 Dec 13;8(12):e83687. doi: 10.1371/journal.pone.0083687. eCollection 2013.
10
Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.慢性肾病引起的心脏纤维化可通过降低循环中不可透析的尿毒症毒素吲哚硫酸酯的水平得到改善。
PLoS One. 2012;7(7):e41281. doi: 10.1371/journal.pone.0041281. Epub 2012 Jul 19.